Biofilm Formation Avoids Complement Immunity and Phagocytosis of Streptococcus pneumoniae
Mirian Domenech(Centro de Investigación Biomédica en Red de Enfermedades Respiratorias), José Yuste(Universidad Rey Juan Carlos), Elisa Ramos‐Sevillano(Centro de Investigación Biomédica en Red de Enfermedades Respiratorias), Ernesto Garcı́a(Consejo Superior de Investigaciones Científicas), Miriam Moscoso(Centro de Investigación Biomédica en Red de Enfermedades Respiratorias)
Cited by 162
Related Papers
Trends in invasive bacterial diseases during the first 2 years of the COVID-19 pandemic: analyses of prospective surveillance data from 30 countries and territories in the IRIS Consortium
|The Lancet Digital Health|2023|157
<i>Streptococcus pneumoniae</i> Resistance to Complement-Mediated Immunity Is Dependent on the Capsular Serotype
|Infection and Immunity|2009|117
Nationwide Trends of Invasive Pneumococcal Disease in Spain From 2009 Through 2019 in Children and Adults During the Pneumococcal Conjugate Vaccine Era
|Clinical Infectious Diseases|2020|113
Impaired Opsonization with C3b and Phagocytosis of<i>Streptococcus pneumoniae</i>in Sera from Subjects with Defects in the Classical Complement Pathway
|Infection and Immunity|2008|110
Serum Amyloid P Aids Complement-Mediated Immunity to Streptococcus pneumoniae
|PLoS Pathogens|2007|106